Vimpat: new antiepileptic for partial seizuresUCB Canada is introducing Vimpat as adjunctive therapy in the management of epilepsy. Peoples’ jobs linked to area of brain degenerationFor physicians with a patient presenting with signs of dementia, the person’s career path may provide clues about their brain health. ‘Destination amnesia’ could impair patient encounters Facing autism A focus on diagnosis, current controversies and proven treatments. First oral MS drug approved in U.S. Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Two Canadian centres win stroke care honours Calgary, Toronto Rehab earn new accreditation Stroke costs in Canada found to be double previous estimates Price-tag for first six months after ischemic stroke: close to $50,000 Community program reduces cardiovascular hospitalization rate Teaching volunteer peer educators about risk factors and how to reduce them proves effective in Canadian study Apixaban reduces AF patients’ stroke risk compared with ASA Agent tested in atrial fibrillation patients who are unsuitable for warfarin therapy Daughters more prone to depression than sons when caring for parent with stroke Supports needed for family members who are “critical” to stroke recovery: MD First Previous 51 52 53 54 55 Next Last
